OpenVSafe by OpenVAERS
Search V-safe

DK8-10959-81247

3 vaccinations 8 coded responses 26 check-ins 8 free-text entries 7 call cases
Sex
Male
Age at first dose
31-35
ZIP prefix
921 / CA
Registered
2020-12-31
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-25
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-31
    Registered in v-safe
  3. 2021-01-01
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-01-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  6. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-01-13
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to do your normal daily activities
    1 call case(s)
  9. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  10. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  11. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Fatigue or tiredness
    Adult check-in
  12. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  13. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-04
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-16
    Survey response — day 35, dose 2
    MedDRA: Dyspnoea, Headache, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Tachycardia, sob, headache
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-02-16
    Report sent to call center — day 35, dose 2
    Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  20. 2021-02-23
    Survey response — day 42, dose 2
    MedDRA: Specialist consultation, Tachycardia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Symptoms: Tachycardia with minimal exertion · Healthcare visit (other): Cardiologist referral
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-02-23
    Report sent to call center — day 42, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  22. 2021-04-13
    Survey response — 3 months, dose 2
    MedDRA: Medical counselling, Postural orthostatic tachycardia syndrome, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: I have been seeing a cardiologist for tachycardia workup. He thinks it is POTS but waiting for final testing to rule put other causes. These symptoms came on about 3 weeks after the vaccine and have been occurring since then.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-13
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  24. 2021-06-10
  25. 2021-07-01
  26. 2021-07-13
    Survey response — 6 months, dose 2
    MedDRA: Dyspnoea, Office visit, Palpitations, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Palpitations, tachycardia, SOB · Healthcare visit (other): Cardiology follow up
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  27. 2021-07-13
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  28. 2021-07-21
  29. 2021-10-06
    Dose 3 — Pfizer-BioNTech
  30. 2021-10-07
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  31. 2021-10-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain, Redness · None
    Adult check-in
  32. 2021-10-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  33. 2021-10-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  34. 2021-10-12
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  35. 2021-10-15
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  36. 2021-10-27
    Survey response — day 21, dose 3
    MedDRA: Palpitations, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Return of palpitations and tachycardia.
    MedDRA releases: 2024-11 · check-in free text available
  37. 2021-11-03
    Survey response — day 28, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Same as last check in
    MedDRA releases: 2024-11 · check-in free text available
  38. 2021-11-17
    Survey response — day 42, dose 3
    MedDRA: Exercise tolerance decreased, Heart rate increased — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Increased heart rate with postural changes. Decreased exercise tolerance.
    MedDRA releases: 2024-11 · check-in free text available
  39. 2022-01-07
    Survey response — 3 months, dose 3
    MedDRA: Exercise tolerance decreased, Tachycardia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Tachycardia, decreased exercise tolerance
    MedDRA releases: 2024-11 · check-in free text available
  40. 2022-01-07
    Report sent to call center — 3 months, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  41. 2022-01-17

Vaccinations

DoseDateManufacturerCo-administered
12020-12-25Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-10-06Pfizer-BioNTech No

Call center

7 call center cases

7 unsuccessful

See the call center timeline

Free text

Release 4 — day 35, dose 2

2021-02-16

Symptoms: Tachycardia, sob, headache

Release 4 — day 42, dose 2

2021-02-23

Symptoms: Tachycardia with minimal exertion
Healthcare visit (other): Cardiologist referral

Release 7 — 3 months, dose 2

2021-04-13

Symptoms: I have been seeing a cardiologist for tachycardia workup. He thinks it is POTS but waiting for final testing to rule put other causes. These symptoms came on about 3 weeks after the vaccine and have been occurring since then.

Release 9 — 6 months, dose 2

2021-07-13

Symptoms: Palpitations, tachycardia, SOB
Healthcare visit (other): Cardiology follow up

Release 10 — day 21, dose 3

2021-10-27

Symptoms: Return of palpitations and tachycardia.

Release 10 — day 28, dose 3

2021-11-03

Symptoms: Same as last check in

Release 10 — day 42, dose 3

2021-11-17

Symptoms: Increased heart rate with postural changes. Decreased exercise tolerance.

Release 10 — 3 months, dose 3

2022-01-07

Symptoms: Tachycardia, decreased exercise tolerance

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
HCVOSpecialist consultation ✓ ✓ ✓
SDDyspnoea ✓ ✓ ✓
SDExercise tolerance decreased · · ✓
SDHeadache ✓ ✓ ✓
SDHeart rate increased · · ✓
SDMedical counselling ✓ ✓ ✓
SDPalpitations ✓ ✓ ✓
SDPostural orthostatic tachycardia syndrome ✓ ✓ ✓
SDTachycardia ✓ ✓ ✓
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release